UPO book

Brief Research Description

• Co-chair in multicenter, randomized trials (ARMYDA trials) focused on Interventional pharmacology, e.g. optimization of lipid-lowering and antiplatelet therapies in patients undergoing percutaneous coronary intervention. These studies were published on the main international, cardiological journals (Circulation, European Heart Journal, JACC).

• Research activity is also focused on international registries regarding prevention of thromboembolic complications in patients with atrial fibrillation by using newer oral anticoagulant agents and by implementing interventional, non-pharmacological approaches.

• Spontaneous, local research projects also include: new treatments in patients with heart failure; pathogenesis of coronary artery disease; role of inflammation in atherosclerosis; lipidic targets in patients with very high cardiovascular risk; transcatheter procedures related to aortic, tricuspid and mitral valve; diagnostic and prognostic role of more recent echocardiographic techniques; innovative techniques of cardiac pacing; machine learning for stratifying the cardiovascular risk; contemporary techniques of coronary stenting and angioplasty. 

Keywords

atherosclerosis; antiplatelet therapy; lipid-lowering therapy; anticoagulation in atrial fibrillation; percutaneous coronary intervention 

PubMed